Sandoz Matches Teva On US Rifaximin Launch Date
Company Had Been Sued In October Last Year
Sandoz has joined a fellow major generics player, Teva’s Actavis, in settling itself out of litigation with Bausch Health over Xifaxan 550mg tablets in the US. The two settlement agreements contain key similarities and differences.
